Philadelphia University + Thomas Jefferson University


Recent Publications

Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial

Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry

Advancing symptom science through symptom cluster research: Expert panel proceedings and recommendations

Post-treatment problems of African American breast cancer survivors

Symptom Clusters

Defining the Symptom Cluster: How Far Have We Come?

Validity and reliability of the taiwanese version of the general fatigue scale in cancer patients

Management of cancer-related fatigue during chemotherapy through telephone motivational interviewing: Modeling and randomized exploratory trial

Subgroups of cancer patients with unique pain and fatigue experiences during chemotherapy

Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy

Comparison of groups with different patterns of symptom cluster intensity across the Breast Cancer Treatment Trajectory

Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: An update

Recommendations for high-priority research on cancer-related fatigue in children and adults

The personal patient profile-prostate decision support for men with localized prostate cancer: A multi-center randomized trial

Preparing individuals to communicate genetic test results to their relatives: Report of a randomized control trial

Cancer-related fatigue and its impact on functioning

Predictors of depression in breast cancer patients treated with radiation: Role of prior chemotherapy and nuclear factor kappa B

Cancer symptom cluster research: New perspectives and tools

Common biological pathways underlying the psychoneurological symptom cluster in cancer patients

Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: A secondary analysis